<DOC>
	<DOCNO>NCT02866942</DOCNO>
	<brief_summary>A new influenza vaccine , know LAIV ( Live Attenuated Intranasal Vaccine ) recently approve number licensing board give spray nose . In United Kingdom ( UK ) , vaccine demonstrate highly effective influenza infection . Further , despite concern LAIV cause wheeze child age 2 year , previous SNIFFLE study demonstrate safe child 2 year mild-moderate asthma . The objective multicentre study assess safety intranasal LAIV child asthma recurrent wheeze , include severe symptom .</brief_summary>
	<brief_title>Safety Nasal Influenza Immunisation Children With Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Aged 2 18 year old ( inclusive ) Physician diagnosis asthma recurrent wheezing ( hospital specialist ) AND ( ) child age 24 year : ≥2 exacerbation past year require oral steroid observation inhospital beyond 4 hour duration , OR ( ii ) child ≥ 5 year age , receive treatment equivalent least BTS/SIGN step 2 therapy . Written inform consent parent/guardian ( patient age 16 year ) , assent child age 8 year wherever possible . 1 . Admission Paediatric Intensive Care invasive ventilation due respiratory illness precede 2 year . 2 . Contraindications LAIV ( notwithstanding allergy egg protein ) , include : 1 . Hypersensitivity active ingredient , gelatin gentamicin ( possible trace residue ) 2 . Previous systemic allergic reaction LAIV 3 . Previous allergic reaction influenza vaccine ( LAIV ) relative contraindication , must discuss site PI confirm patient suitability 4 . Children/adolescents clinically immunodeficient due condition immunosuppressive therapy : acute chronic leukaemia ; lymphoma ; symptomatic HIV infection ; cellular immune deficiency ; highdose corticosteroids** . **Highdose steroid define treatment course least one month , equivalent dose great 20mg prednisolone per day ( age ) , child 20kg , dose great 1mg/kg/day . NB : LAIV contraindicate use individual asymptomatic HIV infection ; individual receive topical/inhaled/lowdose oral systemic corticosteroid receive corticosteroid replacement therapy , e.g . adrenal insufficiency . 5 . Children adolescents young 18 year age receive salicylate therapy association Reye 's syndrome salicylates wildtype influenza infection . 6. pregnancy 3 . Contraindications vaccination occasion , e.g . due child acutely unwell : 1 . Febrile ≥38.0 degree C last 72 hour 2 . *Acute wheeze last 72 hour require treatment beyond normally prescribed regular use child 's treat healthcare professional 3 . *Recent admission hospital last 2 week acute asthma 4 . *Current oral steroid asthma exacerbation course complete within last 2 week 5 . Any significant condition circumstance , opinion investigator , may either put participant risk participation study , may influence result study , participant 's ability participate study . Items 3b3d relative contraindication : Many child `` difficulttocontrol '' symptom may meet fail meet criterion routine basis . Where present , study centre PIs able authorise participation casebycase basis , assess child lung function time enrolment .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>